Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions.

Published

Journal Article (Review)

The apolipoprotein E (apoE) polymorphism is emerging as a uniquely important genetic modifier that affects functional outcome from both acute and chronic neurological injuries. Recent attention has focused on common denominator mechanisms by which apoE might affect brain injury and/or brain repair responses in clinically diverse diseases. Although endogenous apoE likely serves several adaptive functions in the injured CNS, there is growing evidence that its effect on modifying brain inflammatory responses and providing protection from excitotoxic injury may be central to its protective properties. A more complete understanding of the role that apoE plays in the injured brain has led to novel therapeutic strategies for both acute and chronic neurological disease.

Full Text

Duke Authors

Cited Authors

  • Laskowitz, DT; Vitek, MP

Published Date

  • August 2007

Published In

Volume / Issue

  • 8 / 8

Start / End Page

  • 959 - 969

PubMed ID

  • 17716229

Pubmed Central ID

  • 17716229

Electronic International Standard Serial Number (EISSN)

  • 1744-8042

Digital Object Identifier (DOI)

  • 10.2217/14622416.8.8.959

Language

  • eng

Conference Location

  • England